These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 16415936)

  • 1. [Advanced glycation end products and hyperglycaemia].
    Omsland TK; Bangstad HJ; Berg TJ; Kolset SO
    Tidsskr Nor Laegeforen; 2006 Jan; 126(2):155-8. PubMed ID: 16415936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycation, receptor-mediated cell activation and vascular complications of diabetes.
    Thornalley PJ
    Diab Vasc Dis Res; 2004 May; 1(1):21-2. PubMed ID: 16305051
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.
    Yamagishi S
    Exp Gerontol; 2011 Apr; 46(4):217-24. PubMed ID: 21111800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mechanisms of Inhibition of Advanced Glycation End Products Formation through Polyphenols in Hyperglycemic Condition.
    Khangholi S; Majid FA; Berwary NJ; Ahmad F; Aziz RB
    Planta Med; 2016 Jan; 82(1-2):32-45. PubMed ID: 26550791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
    Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease.
    Cooper ME
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):31S-38S. PubMed ID: 15607433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end-products and the progress of diabetic vascular complications.
    Jakus V; Rietbrock N
    Physiol Res; 2004; 53(2):131-42. PubMed ID: 15046548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic vascular disease: it's all the RAGE.
    Hudson BI; Wendt T; Bucciarelli LG; Rong LL; Naka Y; Yan SF; Schmidt AM
    Antioxid Redox Signal; 2005; 7(11-12):1588-600. PubMed ID: 16356122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end-products and the kidney.
    Busch M; Franke S; Rüster C; Wolf G
    Eur J Clin Invest; 2010 Aug; 40(8):742-55. PubMed ID: 20649640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advanced glycation end products (AGEs) and renal failure].
    Kurowski R; Manitius J
    Przegl Lek; 2006; 63(4):203-8. PubMed ID: 17080743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of glucose and reactive oxygen species in the development of vascular complications of diabetes mellitus].
    Ksiazek K; Wiśniewska J
    Przegl Lek; 2001; 58(10):915-8. PubMed ID: 11957818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kanková K
    Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advanced glycosylation end products and chronic complications of diabetes mellitus].
    Méndez JD
    Gac Med Mex; 2003; 139(1):49-55. PubMed ID: 12666409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD.
    Wu L; Ma L; Nicholson LF; Black PN
    Respir Med; 2011 Mar; 105(3):329-36. PubMed ID: 21112201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE and its ligands: a lasting memory in diabetic complications?
    Yan SF; Ramasamy R; Bucciarelli LG; Wendt T; Lee LK; Hudson BI; Stern DM; Lalla E; DU Yan S; Rong LL; Naka Y; Schmidt AM
    Diab Vasc Dis Res; 2004 May; 1(1):10-20. PubMed ID: 16305050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE: a novel target for drug intervention in diabetic vascular disease.
    Hudson BI; Schmidt AM
    Pharm Res; 2004 Jul; 21(7):1079-86. PubMed ID: 15290845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol.
    Xu L; Wang YR; Li PC; Feng B
    Lipids Health Dis; 2016 Sep; 15(1):161. PubMed ID: 27644038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advanced glycosylation end products (AGE): new toxins?].
    Boulanger E; Dequiedt P; Wautier JL
    Nephrologie; 2002; 23(7):351-9. PubMed ID: 12500421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation endproducts: what is their relevance to diabetic complications?
    Ahmed N; Thornalley PJ
    Diabetes Obes Metab; 2007 May; 9(3):233-45. PubMed ID: 17391149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.